VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,478,088 | -9.4% | 427,597 | +1.7% | 0.02% | -12.0% |
| Q2 2023 | $12,672,000 | -1.0% | 420,590 | +6.1% | 0.02% | -10.7% |
| Q1 2023 | $12,802,000 | -14.0% | 396,311 | -23.5% | 0.03% | -17.6% |
| Q4 2022 | $14,881,902 | +46.5% | 518,328 | +22.6% | 0.03% | +25.9% |
| Q3 2022 | $10,157,000 | -13.3% | 422,696 | -6.3% | 0.03% | -10.0% |
| Q2 2022 | $11,721,000 | -30.7% | 451,300 | +2.4% | 0.03% | -21.1% |
| Q1 2022 | $16,923,000 | +29.9% | 440,780 | +8.2% | 0.04% | +31.0% |
| Q4 2021 | $13,032,000 | -61.6% | 407,292 | -64.7% | 0.03% | -68.1% |
| Q3 2021 | $33,936,000 | -17.6% | 1,153,222 | -4.9% | 0.09% | -23.5% |
| Q2 2021 | $41,186,000 | +3.6% | 1,212,372 | -0.8% | 0.12% | -5.6% |
| Q1 2021 | $39,755,000 | -13.4% | 1,222,149 | +2.9% | 0.13% | -43.2% |
| Q3 2020 | $45,896,000 | +196.1% | 1,187,669 | +178.1% | 0.22% | +161.2% |
| Q2 2020 | $15,500,000 | +410.9% | 427,102 | +223.0% | 0.08% | +325.0% |
| Q1 2020 | $3,034,000 | -56.8% | 132,248 | -44.8% | 0.02% | -51.2% |
| Q4 2019 | $7,016,000 | +9.8% | 239,447 | +0.2% | 0.04% | +17.1% |
| Q3 2019 | $6,390,000 | +7.8% | 239,073 | +3.0% | 0.04% | 0.0% |
| Q2 2019 | $5,930,000 | -57.1% | 232,016 | -62.5% | 0.04% | -62.0% |
| Q1 2019 | $13,819,000 | +540.1% | 618,196 | +492.0% | 0.09% | +441.2% |
| Q4 2018 | $2,159,000 | -84.8% | 104,425 | -86.4% | 0.02% | -83.3% |
| Q3 2018 | $14,206,000 | -21.8% | 768,954 | -5.6% | 0.10% | -28.2% |
| Q2 2018 | $18,177,000 | +109.8% | 814,896 | +102.0% | 0.14% | +94.5% |
| Q1 2018 | $8,666,000 | -48.3% | 403,401 | -44.1% | 0.07% | -47.1% |
| Q4 2017 | $16,765,000 | +57.7% | 721,681 | +55.8% | 0.14% | +51.6% |
| Q3 2017 | $10,634,000 | +3.3% | 463,166 | -0.8% | 0.09% | -1.1% |
| Q2 2017 | $10,299,000 | +12.8% | 467,013 | +16.7% | 0.09% | +5.7% |
| Q1 2017 | $9,132,000 | -24.1% | 400,295 | -30.4% | 0.09% | -33.6% |
| Q4 2016 | $12,032,000 | +3.4% | 575,297 | +30.6% | 0.13% | -3.0% |
| Q3 2016 | $11,637,000 | +3.3% | 440,497 | +8.4% | 0.14% | -4.9% |
| Q2 2016 | $11,262,000 | – | 406,326 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |